nodes	percent_of_prediction	percent_of_DWPC	metapath
Vapreotide—TACR1—trigeminal nerve—intracranial aneurysm	0.273	0.342	CbGeAlD
Vapreotide—TACR1—cranial nerve—intracranial aneurysm	0.195	0.244	CbGeAlD
Vapreotide—SSTR5—brainstem—intracranial aneurysm	0.1	0.125	CbGeAlD
Vapreotide—SSTR2—brainstem—intracranial aneurysm	0.0645	0.0806	CbGeAlD
Vapreotide—SSTR5—cerebellum—intracranial aneurysm	0.0494	0.0617	CbGeAlD
Vapreotide—TACR1—brainstem—intracranial aneurysm	0.0429	0.0536	CbGeAlD
Vapreotide—SSTR2—cerebellum—intracranial aneurysm	0.0318	0.0398	CbGeAlD
Vapreotide—SSTR2—brain—intracranial aneurysm	0.0258	0.0323	CbGeAlD
Vapreotide—TACR1—brain—intracranial aneurysm	0.0172	0.0215	CbGeAlD
Vapreotide—SSTR5—Peptide GPCRs—EDNRA—intracranial aneurysm	0.0172	0.0858	CbGpPWpGaD
Vapreotide—SSTR2—Peptide GPCRs—EDNRA—intracranial aneurysm	0.0158	0.0792	CbGpPWpGaD
Vapreotide—SSTR2—GPCRs, Other—EDNRA—intracranial aneurysm	0.0134	0.0671	CbGpPWpGaD
Vapreotide—TACR1—Peptide GPCRs—EDNRA—intracranial aneurysm	0.0125	0.0623	CbGpPWpGaD
Vapreotide—SSTR5—Peptide ligand-binding receptors—EDNRA—intracranial aneurysm	0.00807	0.0404	CbGpPWpGaD
Vapreotide—SSTR2—Peptide ligand-binding receptors—EDNRA—intracranial aneurysm	0.00745	0.0372	CbGpPWpGaD
Vapreotide—SSTR5—GPCRs, Class A Rhodopsin-like—EDNRA—intracranial aneurysm	0.00632	0.0316	CbGpPWpGaD
Vapreotide—TACR1—G alpha (q) signalling events—EDNRA—intracranial aneurysm	0.00594	0.0297	CbGpPWpGaD
Vapreotide—TACR1—Peptide ligand-binding receptors—EDNRA—intracranial aneurysm	0.00586	0.0293	CbGpPWpGaD
Vapreotide—SSTR2—GPCRs, Class A Rhodopsin-like—EDNRA—intracranial aneurysm	0.00583	0.0292	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—STARD13—intracranial aneurysm	0.00573	0.0286	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—EDNRA—intracranial aneurysm	0.00541	0.0271	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—intracranial aneurysm	0.00531	0.0266	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—STARD13—intracranial aneurysm	0.00529	0.0264	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—EDNRA—intracranial aneurysm	0.00499	0.025	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—CCL2—intracranial aneurysm	0.00423	0.0212	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—STARD13—intracranial aneurysm	0.00416	0.0208	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—EDNRA—intracranial aneurysm	0.00412	0.0206	CbGpPWpGaD
Vapreotide—SSTR5—Peptide ligand-binding receptors—CCL2—intracranial aneurysm	0.00398	0.0199	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—EDNRA—intracranial aneurysm	0.00393	0.0197	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—EDNRA—intracranial aneurysm	0.0038	0.019	CbGpPWpGaD
Vapreotide—SSTR2—Peptide ligand-binding receptors—CCL2—intracranial aneurysm	0.00367	0.0184	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—MMP9—intracranial aneurysm	0.00302	0.0151	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—EDNRA—intracranial aneurysm	0.00299	0.015	CbGpPWpGaD
Vapreotide—TACR1—Peptide ligand-binding receptors—CCL2—intracranial aneurysm	0.00289	0.0144	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	0.00267	0.0133	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	0.00246	0.0123	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—EDNRA—intracranial aneurysm	0.00233	0.0116	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—EDNRA—intracranial aneurysm	0.00215	0.0108	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—EDNRA—intracranial aneurysm	0.00211	0.0106	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—CCL2—intracranial aneurysm	0.00203	0.0102	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—EDNRA—intracranial aneurysm	0.00195	0.00976	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	0.00194	0.00969	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—CCL2—intracranial aneurysm	0.00187	0.00937	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—EDNRA—intracranial aneurysm	0.00169	0.00846	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—EDNRA—intracranial aneurysm	0.00154	0.00769	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—CCL2—intracranial aneurysm	0.00148	0.00738	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—NCF1—intracranial aneurysm	0.00132	0.00662	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—EDNRA—intracranial aneurysm	0.00125	0.00625	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—NCF1—intracranial aneurysm	0.00122	0.00611	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—EDNRA—intracranial aneurysm	0.00115	0.00577	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—CCL2—intracranial aneurysm	0.00104	0.00521	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—CCL2—intracranial aneurysm	0.000962	0.00481	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—NCF1—intracranial aneurysm	0.000961	0.00481	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—EDNRA—intracranial aneurysm	0.000908	0.00454	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—CCL2—intracranial aneurysm	0.000757	0.00379	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CCL2—intracranial aneurysm	0.000616	0.00308	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CCL2—intracranial aneurysm	0.000568	0.00284	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—NOS3—intracranial aneurysm	0.000549	0.00274	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—NOS3—intracranial aneurysm	0.000506	0.00253	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CCL2—intracranial aneurysm	0.000447	0.00224	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—MMP9—intracranial aneurysm	0.00044	0.0022	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—MMP9—intracranial aneurysm	0.000406	0.00203	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—NOS3—intracranial aneurysm	0.000399	0.00199	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—MMP9—intracranial aneurysm	0.00032	0.0016	CbGpPWpGaD
